X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (229) 229
Publication (27) 27
Book Review (22) 22
Newspaper Article (17) 17
Conference Proceeding (13) 13
Book Chapter (5) 5
Book / eBook (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (108) 108
transplantation (104) 104
index medicus (102) 102
humans (87) 87
immunology (74) 74
male (58) 58
female (56) 56
hematopoietic stem cells (54) 54
adult (51) 51
middle aged (43) 43
bone-marrow-transplantation (42) 42
adolescent (36) 36
bone marrow (33) 33
hematology, oncology and palliative medicine (31) 31
stem cells (31) 31
versus-host-disease (31) 31
analysis (30) 30
oncology (30) 30
unrelated donors (24) 24
aged (22) 22
article (22) 22
medical research (22) 22
risk factors (22) 22
child (21) 21
young adult (20) 20
child, preschool (19) 19
medicine, experimental (19) 19
retrospective studies (19) 19
treatment outcome (18) 18
cancer (17) 17
hematopoietic cell transplantation (17) 17
hematopoietic stem cell transplantation (17) 17
hemopoiesis (17) 17
hematopoietic stem cell transplantation - adverse effects (16) 16
hematopoietic stem cell transplantation - methods (16) 16
survival (16) 16
blood (15) 15
stem-cell transplantation (15) 15
children (14) 14
health aspects (14) 14
leukemia (14) 14
stem cell transplantation (14) 14
bone-marrow (13) 13
histocompatibility antigens (13) 13
hla histocompatibility antigens (13) 13
medical colleges (13) 13
research (13) 13
care and treatment (12) 12
infant (12) 12
patient outcomes (12) 12
quality-of-life (12) 12
survival analysis (12) 12
transplantation, homologous (12) 12
transplants & implants (12) 12
unrelated donor (12) 12
disease-free survival (11) 11
risk (11) 11
survival rate (11) 11
tissue donors (11) 11
abridged index medicus (10) 10
alemtuzumab (10) 10
hematologic neoplasms - therapy (10) 10
prognosis (10) 10
quality of life (10) 10
recipients (10) 10
graft-versus-host reaction (9) 9
late effects (9) 9
mortality (9) 9
outcomes (9) 9
pediatrics (9) 9
peripheral blood stem cell transplantation (9) 9
prospective trial (9) 9
t cells (9) 9
adults (8) 8
complications (8) 8
follow-up studies (8) 8
hematopoietic stem cell transplantation - mortality (8) 8
histocompatibility testing (8) 8
long-term survivors (8) 8
population (8) 8
risk-factors (8) 8
surgical procedures, operative (8) 8
transplantation conditioning - methods (8) 8
usage (8) 8
allogeneic transplantation (7) 7
allografts (7) 7
antibodies, monoclonal, humanized (7) 7
bone marrow transplantation (7) 7
colony-stimulating factor (7) 7
ethnicity (7) 7
graft vs host disease - immunology (7) 7
graft vs host disease - mortality (7) 7
hematologic malignancies (7) 7
acute myeloid-leukemia (6) 6
adverse events (6) 6
alleles (6) 6
bone marrow transplantation - methods (6) 6
chemotherapy (6) 6
consensus development project (6) 6
costa rica (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 366 - 374
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 06/2019, Volume 54, Issue 6, pp. 858 - 866
Despite biosimilars of the granulocyte-colony stimulating factor (G-CSF) filgrastim being approved by the European Medicines Agency since 2008, there is still... 
CD34 antigen | Pharmacodynamics | Granulocyte colony-stimulating factor | Peripheral blood | Stem cells | Antibodies | Colony-stimulating factor | Pharmacology | Pharmacokinetics | Leukocytes (granulocytic) | Progenitor cells | Hemopoiesis
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, pp. e103254 - e103254
Graft versus host disease (GvHD) is one of the main complications after hematological stem cell transplantation (HSCT). CAMPATH-1H is used in the... 
NATURAL-KILLER-CELLS | IN-VITRO | LOW-DOSE ALEMTUZUMAB | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | MULTIDISCIPLINARY SCIENCES | UMBILICAL-CORD BLOOD | MONOCLONAL-ANTIBODIES | VERSUS-HOST-DISEASE | T-CELLS | CONDITIONING REGIMEN | Antigens, CD - immunology | Cell Survival - drug effects | Leukocytes, Mononuclear - drug effects | Antigens, Neoplasm - immunology | Cell Separation | Humans | Alemtuzumab | Antigens, CD - analysis | B-Lymphocytes - drug effects | Glycoproteins - immunology | B-Lymphocytes - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Leukocytes, Mononuclear - immunology | Killer Cells, Natural - immunology | Antineoplastic Agents - pharmacology | Killer Cells, Natural - drug effects | Antigens, Neoplasm - analysis | Glycoproteins - analysis | CD52 Antigen | B cells | T cells | Analysis | Stem cells | Cell proliferation | Graft-versus-host reaction | Leukemia | Stem cell transplantation | Cytotoxicity | Leukocytes (mononuclear) | Transplantation | Lymphocytes T | Biology | Cell surface | Blood | Ethics | Cell activation | Cord blood | Consent | Lymphocytes | Peripheral blood mononuclear cells | Bone marrow | Conditioning | Natural killer cells | Antigens | Hematology | Complications | T cell receptors | Immune systems | Depletion | Lymphocytes B | Umbilical cord | Viability | Cancer | Apoptosis | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. S309 - S310
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 03/2019, Volume 54, Issue 3, pp. 425 - 431
A challenge for registries of unrelated hematopoietic stem cell (HSC) donors is to recruit and retain sufficient donors for patients needing transplants. Many... 
BLOOD-DONATION | ONCOLOGY | ATTRITION | IMMUNOLOGY | HEMATOLOGY | MOTIVATIONS | TRANSPLANTATION | Stem cells | Availability | Incentives | External pressure | Transplants | Hematopoietic stem cells | Hemopoiesis
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2019, Volume 37, Issue 19, pp. 1598 - 1600
Journal Article
Cancer, ISSN 0008-543X, 12/2017, Volume 123, Issue 23, pp. 4687 - 4700
Centralized patient‐reported outcome data collection is feasible. Pretransplant patient‐reported outcome scores predict 1‐year survival. 
36‐Item Short Form Health Survey (SF‐36) | Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT‐BMT) | patient‐reported outcomes | survival | transplantation | patient-reported outcomes | 36-Item Short Form Health Survey (SF-36) | Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT-BMT) | PREDICTS | HEMATOPOIETIC-CELL TRANSPLANTATION | FEASIBILITY | BMT CTN | LONG-TERM HEALTH | CHILDREN | Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) | ONCOLOGY | MALIGNANCIES | QUALITY-OF-LIFE | Hematologic Neoplasms - therapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Hematopoietic Stem Cell Transplantation | Male | Data Collection - methods | Transplantation, Homologous | Feasibility Studies | Young Adult | Adolescent | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Transplantation Conditioning | Neoplasm Staging | Child | Patient Reported Outcome Measures | Treatment outcome | Usage | Analysis | Transplantation | Hematopoietic stem cells | Data entry | Quality of life | Transplants & implants | Data acquisition | Syngeneic grafts | Feasibility studies | Bone marrow transplantation | Feasibility analysis | Cures | Patients | Survival | Hemopoiesis | Confidence intervals | Demographics | Bone cancer | Bone marrow | Data collection | Collection | Quartiles | Adults | Children | Specific retention | Cancer | Index Medicus | Abridged Index Medicus | FACT-BMT | Patient-Reported Outcomes | SF-36
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2010, Volume 150, Issue 3, pp. 251 - 258
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 11/2018, Volume 53, Issue 11, pp. 1401 - 1415
Journal Article